All oncologists know how anxiously cancer patients look forward to the availability in clinical practice of drugs that have yielded positive results in the registration trials.
Focus on
In the form of questions and answers the topic of vertigo in hypothyroid subjects is discussed, with particular reference to the possibility that it is an adverse drug reaction. Or maybe not?Can the appearance of vertigo in a patient undergoing therapy with levothyroxine be an adverse event due to...
Columns
Drugs & Children
Intravenous administration of immunoglobulins in pediatrics is used for an increasing number of indications. First of all, primary and secondary immunodeficiencies, but also and more and more frequently, inflammatory and autoimmune diseases such as Kawasaki disease, idiopathic thrombocytopenic...
From regulatory agencies
| 26 September 2021 FDA | 23 September 2021 CADTH |
| 23 September 2021 FDA | 22 September 2021 CADTH |
| 22 September 2021 FDA | 22 September 2021 FDA |
| 21 September 2021 CADTH | 21 September 2021 CADTH |
| 21 September 2021 FDA | 20 September 2021 CADTH |